Elix's Blog

Nov 29, 2023
Molecular Generation of Non-covalent KRAS Inhibitor Candidates Using Machine Learning on Elix Discovery™
- Case Studies
Please click here to check the detail.
Read More
Oct 25, 2023
Efficient and Scalable Framework for Activity Prediction with kMol
- Federated Learning
Please click here to check the detail.
Read More
Oct 25, 2023
Protein – ligand affinity prediction
- Case Studies
Please click here to check the detail.
Read More
Oct 24, 2023
Benchmarking Deployed Generative Models on Elix Discovery
- Generative Models
Please click here to check the detail.
Read More
Oct 26, 2022
Active Learning via Incremental Revelation: Dipeptidyl Peptidase-4 Inhibitors Case Study
- Case Studies
Please click here to check the detail.
Read More
Oct 26, 2022
SmilesFormer: Language Model for Molecular Design
- Generative Models
Please click here to check the detail.
Read More
Oct 26, 2022
Hit to Lead Discovery of Benzylpiperidine Acetylcholinesterase Inhibitors Using Generative Models: a Restrospective Case Study
- Case Studies
Please click here to check the detail.
Read More
Oct 25, 2022
Evaluating Computer-assisted Single-step Retrosynthesis
- Retrosynthesis Models
Please click here to check the detail.
Read More
Jul 3, 2022
An Elix Discovery™ Case Study: Rediscovering Donepezil with an In-house Generative Model
- Case Studies
Please click here to check the detail.
Read More
Jul 3, 2022
An Elix Discovery™ Case Study: Virtual Screening with Confidence Scores
- Case Studies
Please click here to check the detail.
Read More

Contact Us

Thank you for your interest in Elix. If you have any inquiries about our AI drug discovery platform or conducting joint research, or if you would like to conduct an interview with us, please click the Contact button on the right to get in touch with us.
We will respond as soon as possible.